Sponsored Research
Geoffrey S. Ginsburg of Cardiology has received an award (1U01-HG010225-01) from the National Institutes of Health for a project entitled "The IGNITE II CC: Engagement, Coordination, Demonstration, and Dissemination." Total funding will be $4,798,420.
Adrian F. Hernandez of Cardiology has received an award (3U24-AT009676-02S2) from the National Institutes of Health for a project entitled "NIH Health Care Systems Research Collaboratory - Supplement - MOTIFS (Management of Trial Incidental Findings Study)." Total funding will be $1,434,734.
Ravi Karra of Cardiology has received an award (1R03-HL144812-01) from the National Institutes of Health for a project entitled "Angiogenic Approaches to Stimulate Heart Regeneration." Total funding will be $160,585.
William E. Kraus of Cardiology has received an award (3U24-AG047121-03S1) from the National Institutes of Health for a project entitled "Biomarkers of Caloric Restriction in Humans: the CALERIE Biorepository- Supplement." Total funding will be $400,000.
L. Ebony Boulware of General Internal Medicine has received an award (3UL1-TR002553-01S1) from the National Institutes of Health for a project entitled "CTSA Admin Supplement - Hammond/Nordo sIRB Standards." Total funding will be $1,878,612.
L. Ebony Boulware of General Internal Medicine has received an award from the National Institutes of Health for a project entitled "Bruce Burnett IPA." Total funding will be $118,373.
Lori A. Orlando of General Internal Medicine has received an award (1U01-HG010231-01) from the National Institutes of Health for a project entitled "Building and Deploying a Genomic-Medicine Risk Assessment Model for Diverse Primary Care Populations.." Total funding will be $1,822,200.
Lori A. Orlando of General Internal Medicine has received a sub-award () through the Vanderbilt University Medical Center for a project entitled "VGER, The Vanderbilt Genome-Electronic Records Project." Total funding will be $239,952.
Stefanie Sarantopoulos of Hematologic Malignancies and Cellular Therapy has received an award from the Leukemia & Lymphoma Society for a project entitled "The Notch2-BCR Axis: Targeting Drivers of B cell Fate in Chronic GVHD." Total funding will be $200,000.
Nirmish R. Shah of Hematology has received a sub-award () through the Charlotte-Mecklenburg Hospital Authority for a project entitled "SICKLE CELL DISEASE STRUCTURED TRANSITION EDUCATION INTERVENTION WITH PEER MENTORING SUPPORT TO IMPROVING CARE TRANSITIONS (SCD STEP-UP PROGRAM)." Total funding will be $55,945.
J. Brice Weinberg of Hematology has received an award (5R01-HL130763-04S1) from the National Institutes of Health for a project entitled "Nitric Oxide and Microvascular Dysfunction in Severe Malaria." Total funding will be $59,999.
James White of Hematology has received an award (3K01-AG056664-02S1) from the National Institutes of Health for a project entitled "The AMPK/ULK1/p27Kip1 axis regulates autophagy and cell survival in aged satellite cells." Total funding will be $131,598.
Deverick J. Anderson of Infectious Diseases has received an award (200-2016-91776 - Domain 2-TO2) from the Centers for Disease Control and Prevention for a project entitled "RFTOP #2018 Domain 2-B-0001 Base Period ." Total funding will be $794,907.
John A. Bartlett of Infectious Diseases has received a sub-award (2D43-TW009337-07) through the Vanderbilt University Medical Center for a project entitled "Community and physician perceptions of chest pain and prevalence of ischemic ECG features among emergency department patients in Moshi, Tanzania." Total funding will be $74,254.
Vance G. Fowler of Infectious Diseases has received a sub-award (1R21-AI135522-01) through the University of Pittsburgh for a project entitled "Study Network of Acinetobacter as a XDR pathogen (SNAP)." Total funding will be $119,250.
Wendy A. Prudhomme - O'Meara of Infectious Diseases has received an award (1R01-AI141444-01) from the National Institutes of Health for a project entitled "Malaria diagnostic testing and conditional subsidies to target ACTs in the retail sector: the TESTsmART trial." Total funding will be $3,628,471.
Nathan M. Thielman of Infectious Diseases has received a sub-award (2D43-TW009337-07) through the Vanderbilt University Medical Center for a project entitled "Development of a Nurse-Delivered Intervention to Address Hypertension among HIV-infected Adults in Tanzania." Total funding will be $27,415.
L. Gayani Tillekeratne of Infectious Diseases has received a sub-award (2D43-TW009337-7) through the Vanderbilt University Medical Center for a project entitled "A Tiered Algorithm for Predicting Severity of Acute Lower Respiratory Tract Infections in Sri Lanka." Total funding will be $87,530.
James Abbruzzese of Medical Oncology has received an award (5UM1-CA186704-04) from the National Institutes of Health for a project entitled "Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)." Total funding will be $216,435.
James Abbruzzese of Medical Oncology has received an award (3UM1-CA186704-04S1) from the National Institutes of Health for a project entitled "Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)." Total funding will be $170,750.
Jeremy Force of Medical Oncology has received a sub-award () through the Fox Chase Cancer Center for a project entitled "A Randomized Phase II clinical trial assessing the Efficacy and Safety ofMK-3475 (pembrolizumab) in combination with carboplatin and gemcitabine inpatients with metastatic triple negative breast cancer." Total funding will be $211,327.
P. Kelly Marcom of Medical Oncology has received a sub-award () through the Johns Hopkins University for a project entitled "Translational Breast Cancer Research Consortium 2018 Infrastructure - SGK." Total funding will be $75,000.
P. Kelly Marcom of Medical Oncology has received a sub-award () through the Johns Hopkins University for a project entitled "Translational Breast Cancer Research Consortium 2018 Infrastructure (BCRF)." Total funding will be $37,500.
Kevin C. Oeffinger of Medical Oncology has received an award (2R01-CA134722-06A1) from the National Institutes of Health for a project entitled "EMPOWER Study: Promoting BC Screening in Women Who Survived Childhood Cancer." Total funding will be $3,205,412.
April Deveaux (Mentor: Steven Patierno) of Medical Oncology has received an award (3P20-CA202925-03S1) from the National Institutes of Health for a project entitled "Race-related differential splicing of the insulin receptor and prostate tumor cell biology." Total funding will be $208,871.
Yi Wen (Mentor: Steven D. Crowley) of Nephrology has received an award from the American Heart Association for a project entitled "Tissue-specific generation of tumour necrosis factor-a contributes to the pathogenesis of hypertension." Total funding will be $26,844.
Christina M. Wyatt of Nephrology has received an award (7R01-DK112258-02) from the National Institutes of Health for a project entitled "Impact of early antiretroviral therapy on kidney disease outcomes." Total funding will be $2,046,168.
Loretta Que of Pulmonary has received an award from the American Lung Association for a project entitled "Pilot: Zinc Acetate to Treat Chronic Refractory Cough (ZICO)."
Virginia B. Kraus of Rheumatology has received an award (1R56-AG060895-01) from the National Institutes of Health for a project entitled "Extracellular Vesicles and Their Role in Hallmarks of Aging." Total funding will be $659,035.
Industry-sponsored Clinical Trials
Gary M. Felker of Cardiology has received an award from Roche Diagnostics for a project entitled "GDF-15 FIGHT/RD003507." Total funding will be $47,446.
Kevin P. Jackson of Cardiology has received an award from Medtronic, Inc. for a project entitled "ECG Belt." Total funding will be $217,340.
William S. Jones of Cardiology has received an award from Pluristem Therapeutics Inc. for a project entitled "PACE-CLI (PLX-CLI-03)." Total funding will be $187,148.
Raymond J. Kim of Cardiology has received an award from Zoll Medical Corporation for a project entitled "STEMI COOL." Total funding will be $994,176.
Stephen E. Robinson of Cardiology has received an award from Novartis Pharmaceuticals Corporation for a project entitled "CONNECT-HF-Raleigh." Total funding will be $33,250.
Tracy Y. Wang of Cardiology has received an award from Bristol-Myers Squibb Company for a project entitled "Optimizing anticoagulation dosing and adherence for patients with non-valvular atrial fibrillation (ARISTA)." Total funding will be $800,001.
Thomas J. Weber of Endocrinology has received an award from Ultragenyx Pharmaceutical for a project entitled "X-linked Hypophosphatemia Disease Monitoring Program (XLH-DMP) UX023-CL401." Total funding will be $306,126.
Manal F. Abdelmalek of Gastroenterology has received an award from Enanta Pharmaceuticals, Inc. for a project entitled "A Phase 2 Dose Ranging, Randomized Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects with Non-Alcoholic Steatohepatitis (NASH) EDP 305-101." Total funding will be $99,461.
Barbara D. Alexander of Infectious Diseases has received an award from Leadiant Biosciences, Inc. for a project entitled "Efficacy & Safety of Aerosolized Abelcet in the Lung Transplant Population.." Total funding will be $166,772.
Chris Woods of Infectious Diseases has received a sub-award () through Institute for Medical Research, Inc. for a project entitled "IMR PSA: Mark Sprenz." Total funding will be $14,587.
Michael A. Morse of Medical Oncology has received an award from PsiOxus Therapeutics Ltd. for a project entitled "A Phase 1 multicenter, open label study of enadenotucirev combined with PD-1 inhibitor in subjects with metastatic or advanced epithelial tumors." Total funding will be $341,556.
John H. Strickler of Medical Oncology has received an award from Nektar Therapeutics for a project entitled "A PHASE 1/2, OPEN-LABEL, MULTICENTER, DOSE ESCALATION AND DOSE EXPANSION STUDY OF NKTR-262 IN COMBINATION WITH NKTR-214 AND IN COMBINATION WITH NKTR-214 PLUS NIVOLUMAB IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC SOLID TUMOR MALIGNANCIES." Total funding will be $585,905.
Patricia Lugar of Pulmonary has received an award from CSL Behring LLC for a project entitled "IgPro20_1001 Phase I, Comparison of 2 infusion devisces with respet to Pharmacokinetics, safety, and tolerability of Hizentra: an investigational wearable infusor and Crono S-PID-50 Infusion Pump." Total funding will be $74,842.
Lake D. Morrison of Pulmonary has received an award from Nitto Denko Corporation for a project entitled "ND-L02-s0201-005 Phase 2 randomized double blind placebo controlled study to evaluate safety, tolerability, biological activity, and PK of ND-L02-s0201 in subjects with IPF." Total funding will be $235,954.